Display options
Cite
Jopling H, Yates A, Burgoyne N, et al. Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay. Endocrinol Diabetes Metab. 2018;1(4):e00021doi: 10.1002/edm2.21.
Jopling, H., Yates, A., Burgoyne, N., Hayden, K., Chaloner, C., & Tetlow, L. (2018). Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay. Endocrinology, diabetes & metabolism, 1(4), e00021. https://doi.org/10.1002/edm2.21
Jopling, Helen, et al. "Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay." Endocrinology, diabetes & metabolism vol. 1,4 (2018): e00021. doi: https://doi.org/10.1002/edm2.21
Jopling H, Yates A, Burgoyne N, Hayden K, Chaloner C, Tetlow L. Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay. Endocrinol Diabetes Metab. 2018 Jul 18;1(4):e00021. doi: 10.1002/edm2.21. eCollection 2018 Oct. PMID: 30815559; PMCID: PMC6354749.
Copy Download .nbib Format: NLM
Share it on

Endocrinol Diabetes Metab. 2018 Jul 18;1(4):e00021. doi: 10.1002/edm2.21. eCollection 2018 Oct.

Paediatric Anti-Müllerian Hormone measurement: Male and female reference intervals established using the automated Beckman Coulter Access AMH assay.

Endocrinology, diabetes & metabolism

Helen Jopling, Allen Yates, Nicholas Burgoyne, Katharine Hayden, Christopher Chaloner, Lesley Tetlow

Affiliations

  1. Department of Clinical Biochemistry Manchester University NHS Foundation Trust Manchester UK.
  2. Burgoyne Data Science Consultancy Manchester UK.

PMID: 30815559 PMCID: PMC6354749 DOI: 10.1002/edm2.21

Abstract

OBJECTIVE: Anti-Müllerian Hormone (AMH) concentration is high at birth in males, demonstrating the presence of functional testicular tissue in the prepubertal period, and acting as a useful marker in the investigation of paediatric reproductive disorders. AMH also provides a tool in the investigation of female virilization, premature ovarian failure and polycystic ovarian syndrome in childhood. Robust, assay-specific paediatric AMH reference intervals are therefore required for clinical interpretation of results. The aim of this study was to derive age-specific AMH reference intervals for males and females aged 0-18 years.

DESIGN AND PATIENTS: Plasma samples were obtained from patients at Royal Manchester Children's Hospital and analysed for AMH using the automated Beckman Coulter Access AMH Assay. Patients under investigation for paediatric reproductive or endocrine disorders were excluded from the study.

MEASUREMENTS: Seven hundred and 2 patient plasma samples (465 male, 237 female) were subject to AMH measurement, and results were analysed in order to derive continuous and discrete reference intervals for the paediatric age range.

RESULTS: Clear discrimination between male and female AMH results was evident in the prepubertal age range, with some overlap between the genders following pubertal onset.

CONCLUSIONS: We have derived age-related reference intervals for plasma AMH in the paediatric age range (0-18 years) using the automated Beckman Coulter Access AMH assay which will aid in the investigation of paediatric endocrine disorders such as disorders of sexual development.

Keywords: Anti‐Müllerian Hormone; disorders of sex development; immunoassay; ovarian reserve; paediatrics; reference values; testicular hormones

References

  1. Clin Chem Lab Med. 2002 Oct;40(10):1040-7 - PubMed
  2. Clin Chim Acta. 2003 Aug;334(1-2):5-23 - PubMed
  3. Mol Cell Endocrinol. 2003 Dec 15;211(1-2):55-63 - PubMed
  4. Clin Endocrinol (Oxf). 2010 Jun;72(6):814-9 - PubMed
  5. Horm Res Paediatr. 2010;73(2):81-92 - PubMed
  6. J Clin Endocrinol Metab. 2010 Nov;95(11):5003-10 - PubMed
  7. J Immunol Methods. 2010 Oct 31;362(1-2):51-9 - PubMed
  8. J Clin Endocrinol Metab. 2010 Dec;95(12):5357-64 - PubMed
  9. PLoS One. 2011;6(7):e22024 - PubMed
  10. Int J Gen Med. 2011;4:759-63 - PubMed
  11. Clin Chem. 2012 May;58(5):854-68 - PubMed
  12. Hum Reprod. 2012 Oct;27(10):3085-91 - PubMed
  13. J Clin Endocrinol Metab. 2012 Dec;97(12):4650-5 - PubMed
  14. Horm Res Paediatr. 2013;79(1):17-21 - PubMed
  15. J Pediatr Endocrinol Metab. 2012;25(9-10):983-9 - PubMed
  16. Fertil Steril. 2014 Jan;101(1):227-31 - PubMed
  17. Int J Endocrinol. 2013;2013:198698 - PubMed
  18. J Clin Endocrinol Metab. 2014 Mar;99(3):723-32 - PubMed
  19. Hum Reprod Update. 2014 May-Jun;20(3):370-85 - PubMed
  20. Hum Reprod. 2014 May;29(5):1042-8 - PubMed
  21. J Pediatr Endocrinol Metab. 2014 Nov;27(11-12):1175-9 - PubMed
  22. Fertil Steril. 2015 Feb;103(2):554-59.e1 - PubMed
  23. J Clin Endocrinol Metab. 2015 Jul;100(7):E1030-8 - PubMed
  24. J Pediatr Endocrinol Metab. 2015 Sep;28(9-10):1153-62 - PubMed
  25. Fertil Steril. 2015 Oct;104(4):1016-1021.e6 - PubMed
  26. Clin Endocrinol (Oxf). 2016 May;84(5):771-88 - PubMed
  27. J Assist Reprod Genet. 2015 Nov;32(11):1691-6 - PubMed
  28. Clin Biochem. 2016 Feb;49(3):260-7 - PubMed
  29. Reprod Biol Endocrinol. 2016 Feb 16;14:8 - PubMed
  30. J Pediatr Adolesc Gynecol. 2016 Dec;29(6):599-603 - PubMed
  31. J Clin Endocrinol Metab. 2016 Sep;101(9):3288-96 - PubMed
  32. Clin Biochem. 2016 Nov;49(16-17):1267-1273 - PubMed
  33. J Clin Endocrinol Metab. 1996 Feb;81(2):571-6 - PubMed

Publication Types